Mismatch repair, p53 and chromosomal aberrations in primary colorectal carcinomas

Acta Oncologica

Volumn 45, Issue 1, 2006, Pages 61-66

  Mehigan, Brian J ^a   Ashman, James N E ^a   Baker, Richard P ^a   Macdonald, Alastair ^b   Greenman, John ^a   Monson, John R T ^a   Cawkwell, Lynn ^a,c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; COLORECTAL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; MISMATCH REPAIR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

BASE PAIR MISMATCH; CARRIER PROTEINS; CHROMOSOME ABERRATIONS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA REPAIR; GENES, P53; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 32244446983     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860500374463     Document Type: Article

References (21)

1. Haydon AMM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002;3:83-8.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, et al. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-8.
4. Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, et al. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999;52:455-60.
5. Cawkwell L, Gray S, Murgatroyd H, Sutherland F, Haine L, Lonyfellow M, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective MMR. Gut 1999;45:409-15.
6. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043-8.
7. Kaserer K, Schmaus J, Bethge U, Migschitz B, Fasching S, Walch A, et al. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J Pathol 2000;190:450-6.
8. Lane DP. Cancer. p53, guardian of the genome. Nature 1992;358:15-6.
9. Baker SJ, Preisinger AC, Jessup JM, Paraskera C, Markoisitz S, Willson JK, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
10. Stafford ND, Ashman JN, MacDonald AW, Ell SR, Monson JR, Greenman J. Genetic analysis of head and neck squamous cell carcinoma and surrounding mucosa. Arch Otolaryngol Head Neck Surg 1999;125:1341-8.
11. Smyth EF, Sharma A, Sivarajasingham N, Hartley J, Monson JRT, Cawkwell L. Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer. Dis Colon Rectum 2004;47:2086-92.
12. Curtis LJ, Georgiades IB, White S, Bird CC, Harrison DJ, Wyllie AH. Specific patterns of chromosomal abnormalities are associated with RER status in sporadic colorectal cancer. J Pathol 2000;192:440-5.
13. Li LS, Kim NG, Kim SH, Park C, Kim M, Kang MJ, et al. Chromosomal imbalances in the colorectal carcinomas with microsatellite instability. Am J Pathol 2003;163:1429-36.
14. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, Lafuente A, et al. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 2004;25:1345-57.
15. Leslie A, Pratt NR, Gillespie K, Sales M, Kernohan NM, Smith G, et al. Mutations of APC, K-ras, and p53 are associated with specific chromosomal abberations in colorectal adenocarcinomas. Cancer Res 2003;63:4656-61.
16. Bond GL, Hu W, Levine AJ. MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets 2005;5:3-8.
17. Georgiades IB, Curtis LJ, Morris RM, Bird CC, Wyllie AH. Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene 1999;18:7933-40.
18. Tang R, Changchien CR, Wu M-C, Fan CW, Liu KW, Chen JS, et al. Colorectal cancer without high microsatellite instability and chromosomal instability - an alternative genetic pathway to human colorectal cancer. Carcinogenesis 2004;25:841-6.
19. Vendrell E, Morales C, Risques R-A, Capella G, Peinado MA. Genomic determinants of prognosis in colorectal cancer. Cancer Letters 2005;221:1-9.
20. Gervaz P, Bucher P, Morel P. Two colons-two cancers: Paradigm shift and clinical implications. J Surg Oncol 2004;88:261-6.
21. Munro AJ, Lain S, Lane DP. P53 abnormalities and outcomes in colorectal cancer: A systematic review. Br J Cancer 2005;92:434-44.